Parallel artificial membrane permeability assay (PAMPA) is arising in ADMET screening as a powerful tool to determine the passive permeability of new potential chemical entities. In an attempt to set up a sensitive high throughput method to assess passive blood-brain barrier (BBB) penetration we focused our attention on the effect of solvent and the influence of phospholipids on the permeability in PAMPA. Moreover, the high throughput nature of the assay was maximized by decreasing the incubation time and performing the assay in a cassette mode. UPLC system coupled with a mass spectrometer enormously reduces the analytical time, contemporaneously increasing the sensitivity of the method. Papp values obtained from PAMPA were compared to permeability values from MDCKII-MDR1 assay. Evaluation of the two in vitro models with in vivo data was performed to test the predicting capacity of the two methods. Their contemporary assessment was shown to be an helpful tool in understanding the prevalent mechanism of penetration through the BBB. © 2007 Elsevier B.V. All rights reserved.

Evaluation of in vitro brain penetration: Optimized PAMPA and MDCKII-MDR1 assay comparison / S. Carrara, V. Reali, P. Misiano, G. Dondio, C. Bigogno. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 345:1-2(2007), pp. 125-133.

Evaluation of in vitro brain penetration: Optimized PAMPA and MDCKII-MDR1 assay comparison

P. Misiano;
2007

Abstract

Parallel artificial membrane permeability assay (PAMPA) is arising in ADMET screening as a powerful tool to determine the passive permeability of new potential chemical entities. In an attempt to set up a sensitive high throughput method to assess passive blood-brain barrier (BBB) penetration we focused our attention on the effect of solvent and the influence of phospholipids on the permeability in PAMPA. Moreover, the high throughput nature of the assay was maximized by decreasing the incubation time and performing the assay in a cassette mode. UPLC system coupled with a mass spectrometer enormously reduces the analytical time, contemporaneously increasing the sensitivity of the method. Papp values obtained from PAMPA were compared to permeability values from MDCKII-MDR1 assay. Evaluation of the two in vitro models with in vivo data was performed to test the predicting capacity of the two methods. Their contemporary assessment was shown to be an helpful tool in understanding the prevalent mechanism of penetration through the BBB. © 2007 Elsevier B.V. All rights reserved.
BBB permeability screening; High throughput screening; MDCKII-MDR1; PAMPA; UPLC/MS
Settore CHIM/08 - Chimica Farmaceutica
Settore CHIM/01 - Chimica Analitica
2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
Carrara_2007.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 779 kB
Formato Adobe PDF
779 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/240096
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 56
social impact